Consumer Trends

Unilever and Nestlé Are Fleeing Ice Cream. Private Equity Is Racing In. They Can't Both Be Right.

Here is a puzzle worth a minute. The two largest ice cream conglomerates on earth have both decided the business is not worth being in. At the same time, investors keep pouring money into premium ice cream startups like Van Leeuwen, which went from ten scoop shops to more than a hundred in a handful of years. Somebody is misreading this market. Figuring out who tells you something real about where food margins actually come from.

What the giants concluded

Start with the retreat, because it is stark. Unilever, the biggest player at 21% of industry sales, owns Ben & Jerry's, Breyers, Magnum, and Talenti, and its ice cream division became the company's weakest link, growing just 2.3% in 2024 against 7% company-wide, with volume down 6%. Unilever moved to spin the division off. Nestlé, with Häagen-Dazs and Dreyer's and roughly 13% of the market, reached a similar conclusion about its own frozen portfolio.

Two companies with the leading brands, enormous scale, and every distribution advantage looked at ice cream and decided to leave. That is not a casual signal. When the incumbents with the most structural advantages exit a category, the usual reason is that the category's economics have turned against exactly the thing they are good at.

Why scale stopped working

The giants are built for a specific game: massive volume, wide distribution, aggressive cost control, thin margins made whole by sheer quantity. That model has a vulnerability the freezer aisle exposes brutally.

Switching costs in ice cream are essentially zero. It takes seconds to reach for a different pint, and there is no loyalty program, contract, or habit strong enough to hold a customer who wants to try something else. In a commodity product with no switching costs, you compete mostly on price, and competing on price is a race that grinds margins toward nothing.

Legacy ice cream got caught in that grind. The brands built on being reliable and affordable found themselves unable to raise prices without losing volume, and unable to cut costs enough to matter, while consumers drifted toward either cheaper private label or pricier novelty. The middle, where the giants live, got squeezed from both ends. Scale, their great advantage, turned out to be leverage on a business whose margins were disappearing.

What the upstarts figured out

Now the other side of the paradox, and the reason it is not actually a contradiction.

Van Leeuwen is not playing the same game. Its base is a dense French-style custard at roughly 18% butterfat, well above the 10% the law requires and the 12% in many premium brands, with no stabilizers or artificial flavors. That formulation is the entire strategy, and it inverts the giants' problem.

The insight is that ice cream has two completely different markets wearing the same name. One is a commodity, bought on price, where scale and thin margins rule and the giants are trapped. The other is an affordable luxury, bought on experience, where the customer is choosing to indulge and price sensitivity nearly vanishes. A $12 pint and a $4 pint are not competing products; they are serving different moments and different motivations.

Van Leeuwen built for the second market, and that market has structurally better economics. When someone is buying a treat rather than a staple, higher butterfat and clean-label ingredients are not costs to be minimized. They are the product, the reason the customer will pay a premium and, crucially, the reason switching costs stop being zero. A commodity pint is interchangeable. A pint someone seeks out specifically because of how it is made is not, which is the one thing the legacy model could never manufacture.

The two trends doing the work

The timing helps, and it is worth naming because it explains why now.

The first is clean-label demand, the broad consumer move toward food with recognizable ingredients and nothing synthetic. A recipe of cream, sugar, and real flavorings with no stabilizers is exactly what that movement rewards, and it is the opposite of what mass-market ice cream optimized for, which was shelf stability and cost. What was a manufacturing virtue for the giants, additives that keep a cheap product consistent, became a liability as consumers started reading labels.

The second is the affordable-luxury impulse, the willingness to spend on small indulgences even when budgets are tight. The CEO's own framing captures the category: dessert as a way to be completely present in the moment and feel really good. You cannot charge a premium for presence and pleasure on a commodity. You can on an experience, and a scoop shop where the pistachio cream is poured in front of you is selling the experience as much as the ice cream.

Why the money followed

The investment trail tracks the thesis. Van Leeuwen took a $3.9 million Series A from Strand Equity in 2018, an $18.7 million Series B from NextWorld Evergreen in 2020, and a Stonegate Capital investment in 2022, and over seven years revenue grew roughly tenfold, from 10 scoop shops to 100 and from 100 grocery doors to 12,000.

Private equity is not being sentimental here. It is making a specific bet that the premium segment has the margins and the pricing power the commodity segment lost, and that a brand which cannot be easily substituted can grow into the space the retreating giants are vacating. That is a coherent wager, and the paradox dissolves once you see it: the giants are right that commodity ice cream is a bad business, and the investors are right that premium ice cream is a good one. They are describing two different products.

The part that should temper the enthusiasm

None of which means the upstart path is easy, and it would be a mistake to read the growth story as a guarantee.

Premium scaling has its own failure modes, and they are the mirror image of the giants' problem. The whole proposition rests on quality and craft, and those get harder to preserve as volume climbs. The Van Leeuwen coverage notes the tension directly, a Flavor Lab built next to production specifically to keep innovation close to the customer, precisely because the CEO missed that proximity as the company scaled. That instinct is right, and it is also an admission that scale threatens the thing the brand is selling. Grow too fast or cut the wrong corner, and an affordable luxury quietly becomes just another pint, at which point it inherits the commodity economics it was built to escape.

There is also a demand-side caution. The affordable-luxury impulse is real but not unconditional. In a genuine downturn, a $12 pint is a more discretionary purchase than a $4 one, and the same consumers who trade up in good times trade down in bad ones. The premium thesis is partly a bet on continued willingness to spend on small indulgences, and that willingness is not guaranteed.

Strip it to the principle and this stops being a story about ice cream. The giants fled a business defined by no switching costs and price competition, which is the worst combination in consumer goods. The upstarts are building the opposite: differentiated products where the customer chooses you specifically and will pay for the choice. Same category, opposite economics, and the dividing line is whether the customer can tell your product from the next one and cares about the difference.

Further reading

Written by Vasil V.

This is general information and analysis, not investment or financial advice, and nothing here is a recommendation regarding any company or investment. Figures come from press reporting and company statements. Sources: Bloomberg Businessweek, Restaurant Business, UC Berkeley Business Review, NextWorld Evergreen, and Just Food. Mavengity is editorially independent.
Keep reading

More from Personal Finance

Digital Health

A Physical Therapy Company Is Buying the Most Famous Meditation App in the World

Sword Health, an AI-guided physical therapy company with no consumer brand, is acquiring Headspace, the meditation app that defined digital mental health in the 2010s. The deal is the clearest evidence yet that in health care, the durable moat migrated from brand and users to the enterprise contract.

By Vasil V.·8 min read
Caregiving Economy

The Trillion-Dollar Care System That Sends No Bill and Pays No Wages

American family caregivers provide roughly $1.01 trillion a year of unpaid labor, more than total Medicaid spending. The system captures the savings in budgets and premiums; the sandwich generation, mostly women in their peak earning years, captures none of it, and pays for it in wages, savings, and retirement.

By Vasil V.·8 min read
Consumer Finance

The Fight Over Debt Relief Rules Has Two Sides and One Borrower

A House bill would force debt settlement firms to disclose credit damage, fees, and completion odds. The settlement industry and the lenders' trade group each testified in the borrower's name, but both are paid by the borrower's choices, and disclosure is the one demand that costs neither side a customer it deserves.

By Vasil V.·8 min read
Digital Payments

Every Bank's Youth Account Runs Through a Wallet the Bank Does Not Own

Google's new kid-friendly Wallet balance and Apple Cash Family are quietly training a generation to think of the phone, not the bank, as where money lives. Every youth banking product rides inside a payment surface owned by Apple or Google, and one of those landlords just opened a competing store.

By Vasil V.·8 min read
Employee Benefits

The $5,250 Tuition Benefit Is a 1986 Number

Credit unions ranked among the best workplaces cap education benefits at $5,250, the largest amount the IRS lets an employer give tax-free. The figure was set in 1986 and never moved while tuition tripled and student debt topped $1.86 trillion, until an indexing fix finally arrives in 2027.

By Vasil V.·8 min read
Retirement Planning

The Retirement Advice That Benefits Your Heirs More Than You

The standard playbook for a retiree with more than they'll spend, drain the tax-deferred account first, save the Roth, let the brokerage pass with its stepped-up basis, minimizes the heir's tax bill. It does so partly at the cost of the retiree's own flexibility, and the payoff depends on a future nobody has seen.

By Vasil V.·8 min read
Biotech Economy

The Money Left Massachusetts Biotech Before the Jobs Did

Massachusetts biopharma employment fell for the first time in two decades in 2025, even as the same industry snapshot shows 2026 venture funding up 25 percent and $18 billion in acquisitions. Jobs are the slowest signal in the industry; capital is the fastest, and the two numbers are just describing different years.

By Vasil V.·8 min read
Economy

What Consumers Feel Is the Price Level, Not the Inflation Rate

Inflation is officially cooling to 3.4 percent, but consumer surveys show nearly 80 percent of households still cutting back and a third making extreme choices. The gap is not confusion, it is the difference between a flow the Fed can steer and a stock of accumulated prices that policy can never subtract from.

By Vasil V.·8 min read
Banking Technology

Community Banks Are Buying the Rails to Keep the Deposits

A coalition of 38 state bankers associations is building a shared blockchain network for tokenized deposits, betting that owning the payment rails, not just holding the deposit, is the moat that survives stablecoins. The model they copied has its own history of large members capturing the value.

By Vasil V.·8 min read